AraƱez, Ana Grace B.

HRN: 21-53-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2022
CEFUROXIME 500MG (TAB)
07/09/2022
07/15/2022
PO
500mg
BID
S/P NAsVD With RMLE, Thinly Meconium Stained AF
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: